An IPO from a collections company offers a fresh way to profit as consumers struggle

Dow Jones
2025/06/27

MW An IPO from a collections company offers a fresh way to profit as consumers struggle

By Steve Gelsi

Jefferson Capital is going public after U.S. uncollected consumer loan balances rose 45% in the past five years to a total of $167.8 billion

Jefferson Capital Inc.'s stock received a warm reception on Wall Street on Thursday, as investors aimed to benefit from the company's business in collecting money from unpaid credit cards, auto loans and phone bills.

The total addressable market for these types of loans has grown rapidly as the U.S. economy slows, and struggling consumers face higher interest rates on loans.

Jefferson Capital's stock $(JCAP.UK)$ opened at $19, or 26.7% above the initial public offering price of $15 a share. It has pared some gains to be up 22.3% in recent trading.

The company's stock offering raised $150 million with lead underwriters Jefferies and Keefe, Bruyette & Woods, as it joined the ranks of publicly traded companies such as PRA Group Inc. $(PRAA)$ and Encore Capital Group Inc. $(ECPG)$ that specialize in addressing outstanding consumer debt.

Jefferson Capital sold 10 million shares at $15 a share, at the bottom of the expected pricing range of $15 to $17. With 64.8 million shares outstanding after the IPO, the pricing valued the company at $972.2 million.

Minneapolis-based Jefferson Capital said it ranks as the largest purchaser of nonperforming telecom receivables in the U.S. as well as the largest or second-largest purchaser of both nonperforming and insolvent auto-finance receivables and insolvent consumer receivables.

Basically, the company buys consumers' troubled loans at a discount, then works with the consumers to have them paid back "based on their current financial circumstances."

The cumulative estimated or reported charge-off - money that's not expected to be paid back - on credit cards, personal loans, telecom and utility bills and student loans rose to $167.8 billion in 2024 from $115.7 billion in 2019 in the U.S., according to estimates from Jefferson Capital.

That's a cumulative growth rate of 45.1% over five years.

"In addition to the significant market opportunity in nonperforming consumer finance receivables, there is a much larger opportunity in certain segments of performing consumer finance receivables which include higher risk performing loans and loan portfolios in runoff where we have historically deployed capital at attractive returns," the company said.

It offers a "one-stop liquidity solution" to consumer credit issuers by buying both nonperforming and performing finance receivables, the company said.

Against this backdrop, Jefferson Capital's net income in the first quarter nearly doubled to $64.2 million from $32.9 million in the year-ago period. Revenue grew to $154.9 million from $99.9 million in the year-ago period.

For full-year 2024, Jefferson Capital reported $128.9 million of net income on revenue of $433.3 million, up from $111.5 million of net income and revenue of $323.1 million in 2023.

Private-equity firm J.C. Flowers sold about 7.76 million shares of Jefferson Capital in the IPO for proceeds of about $77.6 million. It's reducing its stake in the company to 67.5% from 81.7%.

Thomas Harding, a managing director at J.C. Flowers, John Oros, former operating partner and managing director at J.C. Flowers, and Thomas Lydon Jr., a vice president at J.C. Flowers, are all on the board of Jefferson Capital.

Also read: This 'AI TechBio' company goes public as IPO demand spreads to biotech

-Steve Gelsi

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

June 26, 2025 12:12 ET (16:12 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10